Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Diagnostics Laboratory, |
RCV000761363 | SCV000891349 | likely pathogenic | Tuberous sclerosis 2 | 2018-06-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000761363 | SCV001517990 | uncertain significance | Tuberous sclerosis 2 | 2022-03-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 623238). This missense change has been observed in individual(s) with tuberous sclerosis complex (TSC) (PMID: 25782670, 31655562). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 612 of the TSC2 protein (p.Leu612Pro). |
Genome- |
RCV000761363 | SCV002039580 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing |